tiprankstipranks
Incannex Healthcare Limited (AU:IHL)
ASX:IHL

Incannex Healthcare Limited (IHL) Share Price & Analysis

1 Followers

IHL Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.04 - AU$0.22
Previous CloseAU$0.04
Volume7.57M
Average Volume (3M)7.02M
Market Cap
AU$1.31B
Enterprise ValueAU$1.27B
Total Cash (Recent Filing)AU$41.68M
Total Debt (Recent Filing)AU$231.99K
Price to Earnings (P/E)N/A
Beta2.09
Feb 27, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,587,011,823
10 Day Avg. Volume12,854,501
30 Day Avg. Volume7,018,209
Standard Deviation2.53
R-Squared0.00357
Alpha0.36
Financial Highlights & Ratios
Price to Book (P/B)1.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

18.01%2.23%2.75%77.01%
18.01% Insiders
2.75% Other Institutional Investors
77.01% Public Companies and
Individual Investors

IHL FAQ

What was Incannex Healthcare Limited’s price range in the past 12 months?
Incannex Healthcare Limited lowest share price was AU$0.04 and its highest was AU$0.21 in the past 12 months.
    What is Incannex Healthcare Limited’s market cap?
    Currently, no data Available
    When is Incannex Healthcare Limited’s upcoming earnings report date?
    Incannex Healthcare Limited’s upcoming earnings report date is Feb 27, 2024 which is 60 days ago.
      How were Incannex Healthcare Limited’s earnings last quarter?
      Incannex Healthcare Limited released its earnings results on Aug 30, 2023. The company reported -AU$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.007.
        Is Incannex Healthcare Limited overvalued?
        According to Wall Street analysts Incannex Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Incannex Healthcare Limited pay dividends?
          Incannex Healthcare Limited does not currently pay dividends.
          What is Incannex Healthcare Limited’s EPS estimate?
          Incannex Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Incannex Healthcare Limited have?
          Incannex Healthcare Limited has 1,587,011,800 shares outstanding.
            What happened to Incannex Healthcare Limited’s price movement after its last earnings report?
            Incannex Healthcare Limited reported an EPS of -AU$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Incannex Healthcare Limited?
              Currently, no hedge funds are holding shares in AU:IHL
              ---

              Company Description

              Incannex Healthcare Limited

              Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              LS Invest Aktiengesellschaft
              Medical Developments International Limited
              Recce Pharmaceuticals Ltd.
              Incannex Healthcare Limited
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis